Chinese Regulators Clear Affymetrix Platform for Clinical Use | GenomeWeb

This article has been updated from a version posted Feb. 16 to include comments from an Affymetrix official.

By Justin Petrone

China's State Food and Drug Administration has cleared Affymetrix's GeneChip System 3000Dx version 2 for in vitro diagnostic use, Affy said last week.

The system is also cleared for IVD use in the US and Japan and has received a CE-IVD mark in the EU.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.